Biotech

All Articles

UK reveals plans to launch 18 brand new scientific trial centers

.Amid a yearslong scientific trial decline in the U.K., a brand-new public-private collaboration has...

UPDATE: Genentech telegrams 93 cutbacks in California after discussing plans to shutter cancer cells immunology analysis device

.Observing the news of a sizable layoff shot in April and also a major restructuring project unveile...

Neurocrine's KarXT competitor hits in stage 2-- however merely at reduced dose

.Neurocrine Biosciences has actually obtained its own hoped-for profile in a phase 2 mental illness ...

Vaderis' rare blood vessel condition drug minimizes nosebleeds

.Vaderis Therapies' target to cultivate the initial medicine targeted primarily at a specific uncomm...

Navigator raises $100M to build new autoimmune pipeline

.Sat nav Medicines has equipped on its own along with $100 million in set A funds as the younger bio...

Duality looks for cash for ADC tests as IPO wave infects Asia

.China's Duality Biotherapeutics has actually filed (PDF) paperwork for a Hong Kong IPO, finding an ...

YolTech sells China civil rights to gene editing and enhancing therapy for $29M

.Four months after Chinese gene modifying provider YolTech Therapeutics took its cholesterol disease...

Addex supply rises after Indivior provides to $300M for substance

.Indivior is getting a small particle allosteric modulator tailored to handle compound usage conditi...

Molecular Allies tweaks AML trial over 'suboptimal visibility'

.Molecular Partners has determined "suboptimal direct exposure" to its tetra-specific T-cell engager...

Despite blended market, a venture capital resurgence may be being available in Europe: PitchBook

.While the biotech investment scene in Europe has reduced rather complying with a COVID-19 backing b...